Virginie Lafont

2.5k total citations
53 papers, 1.9k citations indexed

About

Virginie Lafont is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Virginie Lafont has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 20 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Virginie Lafont's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (18 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Virginie Lafont is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (18 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Virginie Lafont collaborates with scholars based in France, United States and United Kingdom. Virginie Lafont's co-authors include Janny Liautard, Jean Favero, Jean‐Pierre Liautard, Nathalie Bonnefoy, Françoise Sanchez, Jacques Dornand, Jean Pierre Liautard, P. Mangeat, B. Rouot and Andreas Roggenkamp and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Blood.

In The Last Decade

Virginie Lafont

53 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Lafont France 24 936 582 414 237 236 53 1.9k
Erika Hundt Germany 19 500 0.5× 611 1.0× 113 0.3× 62 0.3× 144 0.6× 34 1.5k
Rolf Misselwitz Germany 26 519 0.6× 1.2k 2.1× 100 0.2× 97 0.4× 69 0.3× 77 2.2k
Jean‐François Franetich France 31 784 0.8× 664 1.1× 345 0.8× 22 0.1× 430 1.8× 69 2.9k
Dietmar G. Braun Switzerland 29 703 0.8× 1.3k 2.2× 224 0.5× 61 0.3× 230 1.0× 103 2.6k
Olivier Silvie France 31 820 0.9× 853 1.5× 306 0.7× 21 0.1× 514 2.2× 68 3.0k
Tania F. de Koning‐Ward Australia 35 1.6k 1.7× 1.2k 2.0× 428 1.0× 32 0.1× 552 2.3× 94 4.5k
Katharina Janek Germany 22 478 0.5× 1.1k 1.9× 334 0.8× 48 0.2× 144 0.6× 32 1.7k
Daniel A. Bonsor United States 19 324 0.3× 482 0.8× 151 0.4× 72 0.3× 38 0.2× 33 1.0k
Simon J. North United Kingdom 25 601 0.6× 1.8k 3.1× 120 0.3× 29 0.1× 134 0.6× 33 2.3k
Elaine G. Rodrigues Brazil 29 658 0.7× 705 1.2× 395 1.0× 43 0.2× 743 3.1× 75 2.3k

Countries citing papers authored by Virginie Lafont

Since Specialization
Citations

This map shows the geographic impact of Virginie Lafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Lafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Lafont more than expected).

Fields of papers citing papers by Virginie Lafont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Lafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Lafont. The network helps show where Virginie Lafont may publish in the future.

Co-authorship network of co-authors of Virginie Lafont

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Lafont. A scholar is included among the top collaborators of Virginie Lafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Lafont. Virginie Lafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacot, William, Marie‐Christine Chateau, Simon Thézenas, et al.. (2025). Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers. Cancer Medicine. 14(5). e70615–e70615. 3 indexed citations
2.
Lafont, Virginie, et al.. (2023). Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology. Seminars in Immunopathology. 45(1). 17–28. 16 indexed citations
3.
Boissière‐Michot, Florence, Caroline Mollévi, Séverine Guiu, et al.. (2021). Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer. Cancers. 13(4). 765–765. 20 indexed citations
4.
Boissière‐Michot, Florence, Caroline Mollévi, José Ramos, et al.. (2020). Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers. Cells. 9(6). 1537–1537. 30 indexed citations
5.
Bonnefoy, Nathalie, et al.. (2020). IL-21 Signaling in the Tumor Microenvironment. Advances in experimental medicine and biology. 1240. 73–82. 20 indexed citations
6.
Barjon, Clément, Naoill Abdellaoui, Cécile Déjou, et al.. (2020). Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. Journal of Leukocyte Biology. 107(6). 1057–1067. 38 indexed citations
7.
Michaud, Henri‐Alexandre, O. Becquart, Virginie Lafont, et al.. (2017). PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. OncoImmunology. 6(10). e1353857–e1353857. 10 indexed citations
8.
Bessoles, Stéphanie, et al.. (2011). Role of NKG2D and its ligands in the anti‐infectious activity of Vγ9Vδ2 T cells against intracellular bacteria. European Journal of Immunology. 41(6). 1619–1628. 23 indexed citations
9.
Bessoles, Stéphanie, Sherri Dudal, Gurdyal S. Besra, Françoise Sanchez, & Virginie Lafont. (2009). Human CD4+ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d‐dependent but CD4‐independent mechanisms. European Journal of Immunology. 39(4). 1025–1035. 18 indexed citations
10.
Lafont, Virginie, et al.. (2008). The IFNγ-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophages. Microbial Pathogenesis. 46(2). 88–97. 21 indexed citations
11.
Liautard, Janny, Janny Liautard, Safia Ouahrani‐Bettache, et al.. (2007). Identification and Isolation of Brucella suis Virulence Genes Involved in Resistance to the Human Innate Immune System. Infection and Immunity. 75(11). 5167–5174. 3 indexed citations
12.
Lafont, Virginie, Michael Schaefer, Roland H. Stote, Danièle Altschuh, & Annick Dejaegere. (2007). Protein–protein recognition and interaction hot spots in an antigen–antibody complex: Free energy decomposition identifies “efficient amino acids”. Proteins Structure Function and Bioinformatics. 67(2). 418–434. 89 indexed citations
13.
Lafont, Virginie, Séverine Loisel‐Meyer, Janny Liautard, et al.. (2003). Specific Signaling Pathways Triggered by IL-2 in Human Vγ9Vδ2 T Cells: An Amalgamation of NK and αβ T Cell Signaling. The Journal of Immunology. 171(10). 5225–5232. 16 indexed citations
14.
Dornand, Jacques, Antoine Gross, Virginie Lafont, et al.. (2002). The innate immune response against Brucella in humans. Veterinary Microbiology. 90(1-4). 383–394. 148 indexed citations
15.
Hugo, Nicolas, Virginie Lafont, Mervyn Beukes, & Danièle Altschuh. (2002). Functional aspects of co‐variant surface charges in an antibody fragment. Protein Science. 11(11). 2697–2705. 15 indexed citations
16.
Lafont, Virginie, Janny Liautard, Antoine Gross, Jean Pierre Liautard, & Jean Favero. (2000). Tumor Necrosis Factor-α Production Is Differently Regulated in γδ and αβ Human T Lymphocytes. Journal of Biological Chemistry. 275(25). 19282–19287. 34 indexed citations
17.
Favero, Jean & Virginie Lafont. (1998). Effector pathways regulating T cell activation. Biochemical Pharmacology. 56(12). 1539–1547. 25 indexed citations
18.
Sainte‐Marie, Josette, et al.. (1997). Transferrin Receptor Functions as a Signal‐Transduction Molecule for its Own Recycling Via Increases in the Internal Ca2 Concentration. European Journal of Biochemistry. 250(3). 689–697. 16 indexed citations
19.
Lafont, Virginie, T Fischer, Robert Zumbihl, et al.. (1997). Evidence for a CD4‐associated calcium influx independent of the phosphoinositide transduction pathway in human T cells. European Journal of Immunology. 27(9). 2261–2268. 3 indexed citations
20.
Lafont, Virginie, et al.. (1996). The lectin jacalin triggers CD4-mediated lymphocyte signaling by binding CD4 through a protein-protein interaction. Journal of Leukocyte Biology. 59(5). 691–696. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika Hundt Breakdown of academic impact, for papers by Rolf Misselwitz Breakdown of academic impact, for papers by Jean‐François Franetich Breakdown of academic impact, for papers by Dietmar G. Braun Breakdown of academic impact, for papers by Olivier Silvie Breakdown of academic impact, for papers by Tania F. de Koning‐Ward Breakdown of academic impact, for papers by Katharina Janek Breakdown of academic impact, for papers by Daniel A. Bonsor Breakdown of academic impact, for papers by Simon J. North Breakdown of academic impact, for papers by Elaine G. Rodrigues
Rankless by CCL
2026